NCT06653803

Brief Summary

Background: Although thoracoscopic sympathectomy is made via small incisions, it is associated with severe postoperative pain. Both Rhomboid intercostal block (RIB) and Retrolaminar block (RLB) are recent techniques used for pain control after such procedures Objectives: To compare the effectiveness of RIB and RLB in providing postoperative analgesia after thoracoscopic sympathectomy in adult patients and their impact on the patient's outcomes. Patients and Methods: This prospective, randomized (1:1), double-blind clinical trial; will be carried out on 60 patients scheduled for elective thoracoscopic sympathectomy under general anesthesia at our hospital. Patients will be randomly allocated into two equal groups (30 patients each) and will receive: in group A; general anesthesia with intraoperative ipsilateral ultrasound-guided RIB, whereas in group B; general anesthesia with intraoperative ipsilateral ultrasound-guided RLB.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 21, 2024

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 22, 2024

Completed
9 months until next milestone

Study Start

First participant enrolled

August 1, 2025

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2026

Completed
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2026

Completed
Last Updated

August 21, 2025

Status Verified

July 1, 2025

Enrollment Period

5 months

First QC Date

October 21, 2024

Last Update Submit

August 20, 2025

Conditions

Keywords

Rhomboid Intercostal BlockRetrolaminar BlockRegional Analgesia

Outcome Measures

Primary Outcomes (1)

  • Mean and Standard deviation of time to the first request of postoperative rescue analgesic (minutes) (mean±SD)

    The time interval between the block performance and the first request of postoperative analgesia

    24 hours after the end of surgery

Secondary Outcomes (2)

  • Mean and Standard deviation of Numeric Pain Rating Scale (NPRS) score (mean±SD)

    24 hours after the end of surgery

  • Mean and Standard deviation of the total dose of the rescue analgesic consumed (milligrams) (mean±SD)

    24 hours after the end of surgery

Study Arms (2)

Group A (n=30)

ACTIVE COMPARATOR

Rhomboid Intercostal Block

Procedure: Rhomboid Intercostal Block (RIB)

Group B (n=30)

ACTIVE COMPARATOR

Retrolaminar Block

Procedure: Retrolaminar Block (RLB)

Interventions

Intraoperative Ipsilateral Ultrasound-guided RIB

Group A (n=30)

Intraoperative Ipsilateral Ultrasound-guided RLB

Group B (n=30)

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • American Society of Anesthesiologists (ASA) physical status ≤ II
  • Age from 18 to 60 years
  • Body Mass Index (BMI) \< 35 kg/m²

You may not qualify if:

  • American Society of Anesthesiologists (ASA) physical status \> II
  • Age \< 18 years or \> 60 years
  • Body Mass Index (BMI) ≥ 35
  • Local infection at the puncture site
  • Altered mental status
  • Pregnant women
  • Allergy to study drugs
  • Chronic pain
  • Coagulation abnormalities or on anticoagulants
  • Severe hepatic or kidney disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Damanhour Teaching Hospital

Damanhūr, El-Beheira, Egypt

RECRUITING

MeSH Terms

Conditions

Pain, Postoperative

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Officials

  • Ahmed M Shaat, MD

    Damanhour Teaching Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ahmed M Shaat, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 21, 2024

First Posted

October 22, 2024

Study Start

August 1, 2025

Primary Completion

January 1, 2026

Study Completion

January 30, 2026

Last Updated

August 21, 2025

Record last verified: 2025-07

Locations